Retour

Explorez tous les épisodes du podcast Pharmacy Podcast Network

Plongez dans la liste complète des épisodes de Pharmacy Podcast Network. Chaque épisode est catalogué accompagné de descriptions détaillées, ce qui facilite la recherche et l'exploration de sujets spécifiques. Suivez tous les épisodes de votre podcast préféré et ne manquez aucun contenu pertinent.

Rows per page:

1–50 of 1,813

TitreDateDurée
Beyond the Printer: The Mission to Make Personalized Medicine Accessible to Everyone | CurifyLabs Podcast Series18 Nov 202600:30:39

What if the future of personalized medicine wasn't just about developing new treatments, but transforming how pharmacies prepare medications for individual patients? In this opening episode of the CurifyLabs Podcast Series, we sit down with founders Charlotta Topelius and Niklas Sandler Topelius to explore the inspiration, challenges, and mission behind CurifyLabs. From recognizing limitations in traditional pharmaceutical compounding to envisioning a more standardized, efficient, and scalable approach, the founders share how their commitment to innovation evolved into a mission to make personalized medicines more accessible to patients and the pharmacists who serve them.

 

The conversation goes beyond 3D printing to explore why CurifyLabs developed an integrated compounding ecosystem rather than a standalone device. By bringing together validated formulations, specialized excipient bases, automated mixing and dispensing, quality-control capabilities, and digital batch documentation, CurifyLabs aims to help pharmacies modernize compounding while preserving the essential expertise and clinical judgment of pharmacists. Charlotta and Niklas also share their perspectives on the next generation of personalized medicine, the importance of pharmacist-driven innovation, and their vision for a future where technology helps make individualized treatment more practical, consistent, and accessible.

 

Key Topics Discussed
  • The origin story and entrepreneurial vision behind CurifyLabs.
  • Why personalized medicine needs new approaches to pharmaceutical compounding.
  • The mission to make individualized medications more accessible.
  • Why CurifyLabs developed a complete compounding ecosystem instead of just a pharmaceutical printer.
  • How automation, validated formulations, and standardized workflows can support quality and consistency.
  • The evolving role of pharmacists in technology-enabled personalized medicine.
  • How pharmacist feedback and research influence future innovation.
  • The founders' vision for the next five years of pharmaceutical compounding.

 

The Big Takeaway: CurifyLabs is working toward a future in which personalized medicine is not the exception, but an increasingly practical part of everyday pharmacy care. Its mission goes beyond the technology itself: empowering pharmacists with tools and processes that support individualized treatment while keeping patient needs at the center of innovation.

 

Learn more: https://curifylabs.com/

 

Pharmacy Podcast Network Amplifying the Voice of Pharmacists and Our Profession.

Medicare Part D RFI: What Pharmacies Need CMS to Hear | Outcomes: Insights Beyond the Counter17 Nov 202600:19:22

Featured Guests:

 

  • Mark Olberding — Vice President, Data & Analytics, Outcomes
  • Jon Grice, PharmD, MSA — VP of Pharmacy Insights, Outcomes

 

The Centers for Medicare & Medicaid Services (CMS) is requesting pharmacy industry feedback on establishing reasonable and relevant Medicare Part D pharmacy contracting standards.

 

Mark Olberding and Jon Grice discuss why this Request for Information (RFI) matters and how pharmacies can provide meaningful, data-driven feedback.

 

Key Discussion Points:

 

  • Reimbursement rates, actual drug acquisition costs, and dispensing fees.
  • PBM contract transparency, network participation, and reimbursement predictability.
  • Pharmacy quality measures, audits, and administrative burdens.
  • How contracting practices affect pharmacy sustainability and patient access.
  • Why specific financial data, documented experiences, and real-world examples strengthen submissions.

 

Deadline: November 23, 2026.

 

Pharmacies have an opportunity to help shape future Medicare Part D contracting standards.

 

Submit comments: https://www.regulations.gov/docket/CMS-2026-3037

 

Learn more about Outcomes: https://www.outcomes.com/

 
Marketing in 2027: What's Changing, What's Next, and Where AI Fits | Marketing Vitals16 Nov 202600:33:16

What does the future of digital marketing look like in 2027? In this episode, we're covering the trends to watch, the growing role of AI, and how to use new tools strategically to support your marketing efforts without relying on them to do all the work. Because great marketing still requires human insight, creativity, and strategy.

Evolution of Functional Pharmacy & Supportive Conferences | TWIRx13 Nov 202600:35:32

Friday, November 13, 2026

The Future of Pharmacy: Clinical Innovation, Closures & a New Kind of Conference

Welcome to This Week in Pharmacy, where we bring you the headlines, innovations, and conversations shaping the future of pharmacy care.

Today's episode is sponsored by Independent Pharmacy Cooperative (IPC), supporting the strength and sustainability of independent community pharmacies, and Finch Marketing, helping pharmacy businesses communicate their value, strengthen their brands, and connect with their communities.

This week, we're covering major FDA safety developments, the continued disappearance of community pharmacies, a potentially transformative Medicare payment model, and two important new drug approvals.

Then we're joined by a true pioneer in functional pharmacy, Robert Kress, RPh, to discuss a new kind of pharmacy conference and why the future of the profession may depend on rethinking how pharmacists learn, collaborate, and practice.

Segment 1 — Vox Top 5 Pharmacy News 1. FDA Adds New GLP-1 Safety Warnings

The FDA is requiring updated labeling for GLP-1 receptor agonists, including medications used for diabetes and obesity, over a potential increased risk of a rare eye condition called non-arteritic anterior ischemic optic neuropathy, or NAION.

An FDA review of 126 clinical trials identified 6.4 cases per 100,000 patient-years among GLP-1 users versus 3.8 among comparator patients.

The condition can cause sudden, painless vision loss. Although the absolute risk is low, pharmacists must be prepared to counsel patients, recognize symptoms, and coordinate timely medical evaluation.

Source: FDA Drug Safety Communication

2. More Than 3,000 U.S. Pharmacies Disappear

New research published in the Journal of the American Pharmacists Association reveals that between 2022 and 2024:

  • 7,240 community pharmacies closed.
  • 4,178 new locations opened.
  • The country experienced a net loss of 3,062 pharmacies.

Chain pharmacies represented approximately 2,680 of those net losses, with independents accounting for 382.

Declining reimbursement, PBM practices, and changing retail economics continue to place tremendous pressure on pharmacy access.

Source: Drug Topics — Pharmacy Closures

3. Medicare ACCESS Model Opens New Clinical Opportunities

CMS's ACCESS Model represents an important shift toward outcome-based reimbursement for chronic disease management.

The program supports technology-enabled care for conditions including diabetes, hypertension, chronic pain, and behavioral health.

Participating organizations must meet Medicare enrollment, clinical oversight, and other program requirements. It is not automatic reimbursement for every pharmacist.

NCPA leadership sees potential opportunities for community pharmacies to participate in new clinical care delivery models.

Sources: CMS ACCESS Model | Drug Topics — NCPA Interview

4. FDA Approves First Factor XIa Inhibitor for Stroke Prevention

The FDA approved Sunharbo (asundexian), a new Factor XIa inhibitor used alongside antiplatelet therapy for certain adults following ischemic stroke or high-risk transient ischemic attack.

Results from the OCEANIC-STROKE trial demonstrated a 26% relative reduction in ischemic stroke risk.

The approval introduces an important new mechanism in secondary stroke prevention.

Source: FDA Approval Announcement

5. FDA Approves New Treatment for Rare Joint Tumors

The FDA approved Pimjetmi (pimicotinib) for certain adults with symptomatic tenosynovial giant cell tumors when surgery could cause serious complications or functional limitations.

The oral therapy achieved a 56% response rate compared with 3.2% for placebo in the Phase III MANEUVER trial.

Patients experienced improvements in pain, joint mobility, and physical functioning. The treatment requires appropriate clinical monitoring, including for liver toxicity.

 

Source: FDA Approval

Segment 2 — Special Guest: Robert Kress, RPh The Functional Pharmacy Godfather: A New Kind of Pharmacy Conference

Introduction

For decades, pharmacists have been trained to understand medications, disease states, and treatment protocols. But increasingly, pharmacists are recognizing that truly personalized healthcare requires a broader understanding of lifestyle, nutrition, metabolic health, and the underlying factors influencing patient outcomes.

Our special guest today is Robert Kress, RPh, a pioneer in functional pharmacy, educator, coach, and creator of Orientation-Based Medicine.

Robert has dedicated his work to helping pharmacists expand their clinical thinking and develop more meaningful, patient-centered practices.

Today, we're talking about a new kind of pharmacy conference, one focused on more than traditional education. We're discussing building community, changing clinical perspectives, and preparing pharmacists for an evolving healthcare marketplace.

The Evolution of Functional Pharmacy & Supportive Conferences

Guest Resource: https://www.functionalpharmacy.com/

Special thanks to today's sponsors, Independent Pharmacy Cooperative and Finch Marketing, and to our guest, Robert Kress, RPh.

VOTE for the Pharmacy 50 Awards: Pharmacy50.us 

We Are Main Street! NCPA 2026 Annual Conference Rewind | Part Three12 Nov 202601:06:18

Hosted live in Kansas City, MO – the NCPA held their annual conference this year from October 3rd to the 6th! The Pharmacy Podcast Network brings you this exclusive coverage from within the YARAL Pharma booth, where Todd Eury, Host and CEO of the PPN, talks to vendors, pharmacy owners, and longtime friends in the industry. Listen in as we capture the best moments in conversation at this year's Community Pharmacy Super Bowl, the NCPA 2026 Annual Conference.

 

Thank you to HendrenAI for sponsoring this episode of the NCPA 2026 Rewind!

https://hendren.ai/

 

In this episode, we hear from:

John Boos - CEO of HendrenAI

Brad Tice - RxGenomics ExactMeds

Lucas Morgan & Esq Dae Lee - Buchanan Ingersoll & Rooney PC

Emlah Tubuo, PharmD

Ken Thai, PharmD - 986 Pharmacies

Matt Gilbert - Medsense

Scott Wittnebel - Independent Pharmacy Cooperative (IPC)

Preston Davis, CPhT-Adv - RxTechExam

Bill Eley - American Pharmacy Cooperative, Inc. (APCI)

Honoring Their Service, Advancing Their Care, Protecting Their Future | Veterans Pharmacy Care Summit Podcast Series11 Nov 202600:30:36

This Veterans Day, the Pharmacy Podcast Network proudly honors the extraordinary men and women who have served our nation with the premiere of the Veterans Pharmacy Care Summit Podcast Series.

 

Our veterans answered the call to serve our country. Now it's our responsibility to answer the call to serve them.

 

The annual Veterans Pharmacy Care Summit brings together healthcare professionals, pharmacy innovators, industry leaders, policymakers, and veterans' advocates around one critical mission: improving access to quality healthcare, expanding medication access, and ensuring that no veteran is left behind because of barriers in our healthcare system.

 

Recorded during our Second Annual Veterans Pharmacy Care Summit in Washington, Pennsylvania, this special series explores opportunities to strengthen collaboration between the VA healthcare system, community pharmacies, and emerging healthcare innovators.

 

Our Veterans Day premiere features an outstanding lineup of special guests:

 

  • Jesse McCullough, PharmD — Pharmacy leadership and veteran-centered healthcare advocacy
  • Carmelo Montalvo — CEO, Aethl Bio, discussing innovations in wound care
  • Stephen Beckman — CEO, YARAL Pharma, addressing medication access and healthcare partnerships
  • Pennsylvania State Representative Bud Cook — Representing the 50th Legislative District, discussing the importance of supporting veterans and strengthening healthcare access in our communities

 

From innovative treatment options and medication accessibility to the essential role of independent community pharmacies, these conversations challenge us to rethink how America cares for those who have sacrificed so much.

 

Veterans deserve more than our gratitude. They deserve access, advocacy, innovation, and a healthcare system worthy of their service.

 

On this Veterans Day, we thank every veteran, every military family, and every healthcare professional dedicated to serving those who served.

 

Welcome to the Veterans Pharmacy Care Summit Podcast Series, hosted by Todd Eury on the Pharmacy Podcast Network.

 

Because serving those who served should never end.

 

RxInfluencers – Todd Eury | CPhT Connect10 Nov 202601:03:54

In this episode of CPhT Connect, host Mike Johnston, CPhT-Adv, continues the Rx Influencer series, which spotlights the people leading the pharmacy industry, by sitting down with Todd Eury, CEO of RxPR LLC and founder, publisher, and host of the Pharmacy Podcast Network. Known as the "Rx Podfather," Todd launched the first podcast about the pharmacy profession in 2009. Today his network has produced more than 4,000 episodes and over 5 million downloads. He is also a longtime friend and media partner of NPTA. Todd is usually the one asking the questions, but in this conversation he takes the guest seat. He shares how he went from nearly a decade in telecommunications to selling software for long-term care pharmacies, and how a podcast that started as a "cheat code" for learning the industry grew into the largest podcast network dedicated to pharmacy professionals. Todd also opens up about the risks he took along the way, from a pay cut to enter pharmacy to the financial strain of going all-in on the network, as well as the controversies, online criticism, and sponsor decisions that tested what he stands for. In this episode, we discuss: * Betting on Yourself: Why Todd took a pay cut to enter pharmacy and how the "water down a hill" consistency he built in his early sales career still drives him today. * From Cheat Code to Network: How a one-episode-a-month show built to satisfy Todd's own curiosity became the Pharmacy Podcast Network, and why he says it was never about him, but about bringing in the experts. * Standing for Something: The stories behind Todd's biggest episodes, his toughest moments, and why he believes you have to decide what you will and won't stand for, even when it costs you. * A Profession at an Inflection Point: Todd's perspective on how pharmacy associations are finally collaborating, why pharmacists and technicians absorb the frustration of a system they didn't create, and what he sees coming over the next three to five years. * The Next Evolution: How RxPR, the first public relations firm dedicated exclusively to the pharmacy industry, is taking the network beyond podcasting, including a new evidence-based podcasting seal designed to bring peer-reviewed credibility to audio content. About Our Guest: Todd Eury is the CEO of RxPR LLC and the founder, publisher, and host of the Pharmacy Podcast Network, the largest podcast network dedicated to pharmacy professionals. Affectionately known as the "Rx Podfather," Todd launched the first podcast about the pharmacy profession in 2009. His network has since produced more than 4,000 episodes and over 5 million downloads, covering everything from long-term care and compounding to pediatrics, biosimilars, and cell and gene therapy. Todd's Tip Top 50 awards program, which recognizes the most influential people in pharmacy, was also a direct inspiration for NPTA's Pharmacy Technician IMPACT Awards. Listen now to hear Todd's story of building something bigger than himself, and why he believes the pharmacy profession is on the verge of a golden age. Connect with Todd Eury: Pharmacy Podcast Network: https://pharmacypodcast.com RxPR: https://rxpr.net LinkedIn: https://www.linkedin.com/in/toddeury/

Beyond the Prescription: Unlocking Pharmacy Revenue in 2027 | Outcomes: Insights Beyond the Counter09 Nov 202600:35:54

The pharmacy revenue opportunity doesn't stop at the prescription counter. Ross Frei and Dorrit Trate explore how payer- and pharma-funded programs are creating new ways for pharmacies to get paid for the clinical work, patient engagement and interventions they're uniquely positioned to deliver, plus how pharmacies can prepare to take advantage of those opportunities in 2027.

CVS Breaks Apart, PBM Reform Moves Forward & the Future of Pharmacy Care | TWIRx06 Nov 202601:38:01

November 6, 2026 | Pharmacy Podcast Network

Sponsored by Independent Pharmacy Cooperative (IPC) and U.S. News & World Report

This week on This Week in Pharmacy, Todd Eury welcomes an outstanding lineup of pharmacy leaders, healthcare advocates, and industry experts to discuss four major developments shaping the future of pharmacy: CVS Health's historic restructuring, federal PBM reform, GLP-1 patient outcomes, and innovation in specialty medication access.

Segment 1: CVS Health's Historic Separation — What Happens to 9,000 Pharmacies?

CVS Health has announced plans to separate its retail pharmacy business from its PBM, insurance, and specialty pharmacy operations. What does this mean for community pharmacy profitability, patient access, and the future of vertically integrated healthcare?

Guests:

  • Greg Reybold — APCI
  • Chichi Ilonzo Momah, PharmD, RPh — Owner, Springfield Pharmacy
  • Alec Ginsberg — Chief Operating Officer, C.O. Bigelow Apothecaries
  • https://drugstorecowboy.com/

The big question: If CVS is separating its pharmacies from Caremark, what does that signal about the future business model of community pharmacy?

Segment 2: PBM Reform Becomes Federal Law — What's Next?

Major PBM reforms were enacted through the Consolidated Appropriations Act, signed February 3, 2026, introducing new requirements for transparency, PBM compensation, and pharmacy access.

Congressman Buddy Carter joins IPC's John Covello to examine the legislative victory, the work ahead to implement these reforms, and the fight to protect independent pharmacies.

Guests:

  • U.S. Representative Buddy Carter (R-GA)
  • John Covello — Vice President of Government Relations, Independent Pharmacy Cooperative (IPC)

The big question: Will federal PBM reform finally deliver meaningful financial relief and fairer competition for community pharmacies?

Segment 3: GLP-1 Success — Beyond the Prescription

A new U.S. News & World Report survey explores how patients select GLP-1 telehealth providers and why behavioral support, affordability, and ongoing engagement matter to long-term weight-management success.

Guests:

  • Gretel Schueller — Managing Editor, Health, U.S. News & World Report
  • Kelli Stovall, RPh, MBA — Vice President of Clinical Strategy, Independent Pharmacy Cooperative (IPC)

The big question: How can independent community pharmacists help patients achieve better outcomes beyond dispensing GLP-1 medications?

Read the U.S. News GLP-1 survey

Segment 4: Breaking Down Barriers to Specialty Medications — Sonexus™

Special Guest: Josh Marsh, Vice President & General Manager, Sonexus™ Access and Patient Support, Cardinal Health

Josh Marsh joins Todd to discuss how Cardinal Health's Sonexus™ helps patients overcome barriers to specialty medications.

The conversation explores pharmaceutical Hub Services, benefits verification, prior authorization assistance, financial support, and the growing role of AI and automation in accelerating treatment access.

The big question: How can technology and personalized patient support work together to make specialty medications more accessible?

Report here:

https://cardinalhealth.scene7.com/is/content/corpmarketdms7prod/corp/web/documents/cardinal-health-2026-insourcing-and-outsourcing-trends-report.pdf

 

About This Week in Pharmacy

Hosted by Todd Eury, This Week in Pharmacy delivers news, policy analysis, and exclusive conversations with the professionals shaping the future of pharmacy.

Sponsored by IPC and U.S. News & World Report

Listen and subscribe at PharmacyPodcast.com

Follow the Money, Expose the System, Demand Accountability | PBM Reform with APCI06 Nov 202600:52:50

In this special edition of the PBM Reform Podcast, host Greg Reybold welcomes nationally recognized drug pricing expert Antonio Ciaccia for an unfiltered conversation about pharmacy benefit managers (PBMs), hidden financial incentives, and the growing movement toward meaningful reform.

 

Ciaccia has spent years investigating the economics of prescription drug distribution, helping uncover hundreds of millions of dollars in questionable Medicaid drug spending and exposing the financial mechanisms behind inflated drug prices.

 

His latest work with 3 Axis Advisors raises important questions about whether conventional PBM contracts deliver the savings they promise.

 

An October 2026 analysis compares Mark Cuban Cost Plus Drug Company's published prices with traditional PBM pricing arrangements. Another June 2026 report examines how retrospective rebates, pricing benchmarks, and administrative arrangements create financial risks for employers and health plans.

 

Ciaccia has also described three forces capable of driving PBM reform: legislation, litigation, and market-based competition.

 

As he told Drug Topics, borrowing a familiar expression from Greg Reybold: “Pressure busts pipes.”

 

In This Episode
  • Why PBM pricing transparency remains essential for employers, patients, and pharmacies.
  • What recent drug pricing research reveals about hidden costs and contractual complexity.
  • How cost-plus pharmacy models challenge traditional PBM economics.
  • Why independent pharmacies continue facing reimbursement and cash-flow pressures.
  • Whether federal reform and marketplace competition can produce lasting accountability.
  • How pharmacists, employers, and policymakers can demand measurable results.

 

The future of pharmacy benefits depends on more than promises of reform. It demands transparency, accountability, and evidence that savings actually reach the people paying for healthcare.

 

Join Greg Reybold and Antonio Ciaccia as they follow the money and examine what's next for PBM reform.

We Are Main Street! NCPA 2026 Annual Conference Rewind | Part Two05 Nov 202600:48:39

Hosted live in Kansas City, MO – the NCPA held their annual conference this year from October 3rd to the 6th! The Pharmacy Podcast Network brings you this exclusive coverage from within the YARAL Pharma booth, where Todd Eury, Host and CEO of the PPN, talks to vendors, pharmacy owners, and longtime friends in the industry. Listen in as we capture the best moments in conversation at this year's Community Pharmacy Super Bowl, the NCPA 2026 Annual Conference.

 

Thank you to Outcomes for sponsoring this episode of the NCPA 2026 Rewind!

https://www.outcomes.com/

 

In this episode, we hear from:

Amie Stephens, PharmD - Outcomes

Mark Garofoli, PharmD - PainGuy.us

Lara Zakaria, PharmD - Foodie Pharmacist

Johnny Kello - MatchRx

Fiona Sartoretto Verna - Sartoretto Verna

3D Printing in Compounding: One Pharmacy's Journey and a Discussion for the Industry | CurifyLabs Podcast Series04 Nov 202600:24:25

In Part One of the CurifyLabs Podcast Series, “Trust, Technology & the Future of Compounding,” Pharmacy Podcast Network host Todd Eury is joined by Tenille Davis, PharmD, Chief Advocacy Officer for the Alliance for Pharmacy Compounding (APC), and T.W. Taylor, PharmD, Owner of Williamsburg Drug Co. for a timely conversation about responsible innovation, compliance, and the evolving future of personalized medicine. Together, they explore the state of the compounding industry, opportunities for independent compounding pharmacies, and how pharmacists should evaluate emerging technologies as automation becomes increasingly integrated into pharmacy workflows.

 

The discussion also examines what truly determines compounded dose quality, including the roles of validation, documentation, repeatability, traceability, formulation homogeneity, dispensing accuracy, and pharmacist oversight. Todd and Tenille separate meaningful evidence from marketing claims through “Fact Check: Compounding Edition,” addressing misconceptions such as whether mass uniformity equals content uniformity and whether greater automation automatically means greater quality.

 

The episode sets the foundation for the CurifyLabs series with a central message: the future of compounding depends on bringing technology, evidence, compliance, and pharmacist expertise together to advance personalized patient care responsibly.

What Happens When It All Connects | ONE Journey Ending Fragmentation in Specialty Care with CassianRx03 Nov 202600:32:13

Lumicera runs ONE Journey end to end for specialty pharmacy services — patient engagement, the physician portal, and the patient CRM all operating as a single connected system rather than as separate tools bolted together.

That makes Lumicera the only guest who can close the argument. The first two episodes each show one layer connected, and each ends by pointing at what remains disconnected. Your episode is where the pieces come together: what changes when the patient, the prescriber, the pharmacy workflow, and the data layer are no longer separated by handoffs. Pairing Lumicera's pharmacy leadership with Navitus also brings the payer and PBM lens — including the transparency and incentive dynamics that determine whether a connected journey is even economically possible.

Rewiring Your Nervous System One Breath at a Time with Kathy Ha | The Holistic Pharmacy Podcast02 Nov 202600:58:14

My guest today is a dear friend of mine whom I met in Marie Forleo’s dream club. I have personally experienced a breath work and cold plunge session facilitated by her and her husband/business partner, and it was absolutely phenomenal! I felt reborn and ready for anything after emerging from that process. The husband/wife duo believe resilience isn't about pushing through stress, but about learning to regulate your nervous system so you can meet challenges with clarity instead of reactivity. Tune in to this episode to learn (and get a demo of) practical tools you can use in real time, at work, at home, under pressure, to feel more grounded, present, and fully yourself. Kathy and Michael are the wife-and-husband team behind Terranuma, where they help individuals and organizations build resilience, regulate their nervous systems, and perform at their best under pressure. Their work blends evidence-based breathwork, nervous system training, and mindset practices to support mental clarity, emotional steadiness, and sustainable performance, and they've brought these experiences to executive leadership groups, Entrepreneurs' Organization (EO), Young Presidents' Organization (YPO), first responders, and educators navigating high-stress environments. Michael specializes in breathwork and stress resilience, trained directly under Wim Hof in the Wim Hof Method, as well as in Oxygen Advantage (Patrick McKeown) and XPT Performance Breathing (Laird Hamilton and Gabby Reece). Kathy brings over a decade of experience in high-demand environments, including 14 years as a New York City public school teacher, and is trained in reiki and somatic practices, known for creating grounded, psychologically safe spaces where real transformation can happen. Together, Kathy and Michael create powerful, science-backed experiences that blend presence and human connection, helping people reconnect to themselves so they can lead, perform, and live with more resilience and ease. Connect with Kathy via: Email: kathy@terranuma.co Website: https://www.terranuma.co/ Linked In: http://linkedin.com/in/kathy-ha-112927338

PBM Appeals, Maximizing Your PMS, Financing Growth, Invoice Audits, SBA Updates | The Bottom Line Rewind31 Oct 202600:30:10

Episode 1: A New Playbook for PBM Appeals: https://youtu.be/0ItsA4iQ3zo?si=d_VPQ-P1VVm0f3uR Episode 2: Maximizing Your Pharmacy Management System: https://youtu.be/JycgM_eZFVs?si=Lz2ZWQJRWkGVFoLO Episode 3: Financing Your Pharmacy’s Growth Story: https://youtu.be/Uqgoh3k2bpU?si=O3PeI75iLCqs11Gp Episode 4: Surviving the Invoice Audit: https://youtu.be/LF9hVaPB_pk?si=ahp_jkQcG_w2s9Qu Episode 5: New SBA Rules for Pharmacy Acquisitions: https://youtu.be/2WmVjtZRBVc?si=lNhCDGXCBM1PhCXX Stay connected with us: Facebook: https://www.facebook.com/sykesandco/ LinkedIn: https://www.linkedin.com/company/sykes-company-p-a-/?viewAsMember=true YouTube: https://www.youtube.com/@sykescompanyp.a. TikTok: https://www.tiktok.com/@sykesrxaccounting Instagram: https://www.instagram.com/sykescpa/ Blog: https://www.sykes-cpa.com/blog/

PBMs Under Fire, the World Pharmacist Challenge & CRUSH COST | TWIRx30 Oct 202600:35:24

October 30, 2026 | Pharmacy Podcast Network

Sponsored by CurifyLabs and Independent Pharmacy Cooperative (IPC)

Pharmacy benefit managers are facing new scrutiny, controversial peptides are making headlines, and two pharmacy leaders are joining Todd Eury for a special edition of This Week in Pharmacy.

This week's episode features the finale of the 31 Day Challenge, an exciting announcement about the upcoming WORLD PHARMACIST CHALLENGE, and an exclusive in-studio interview with the 2025 Pharmacy 50 winner, Dr. Grant Harting, PharmD, founder of CRUSH COST.

TWIRx News: The Vox Top 3

1. PBMs Forced to Open Their Books — and They're Fighting Back

The Department of Labor has finalized new PBM transparency requirements covering fees, rebates, spread-pricing revenue, and compensation arrangements involving employer health plans.

The Pharmaceutical Care Management Association (PCMA) argues that the regulation creates unnecessary burdens, threatens smaller PBMs, and could increase costs.

The big question: If PBMs are already transparent, why is additional financial disclosure such a problem?

Read PCMA's response

2. HHS Opens the Door to Six Controversial Peptides

HHS has announced an interim enforcement-discretion policy involving six peptides: BPC-157, Epitalon, KPV, MOTS-c, Semax, and TB-500.

The policy could create a pathway for qualifying 503A compounding pharmacies under specific conditions, even as significant questions remain about the safety and efficacy of these non-FDA-approved substances.

The big question: Is this progress for personalized medicine or a dangerous leap ahead of clinical evidence?

Read the HHS Federal Register notice

3. Congress Investigates Alleged PBM Retaliation Against Independent Pharmacies

House Oversight Committee Chairman James Comer is investigating whether CVS Caremark, Express Scripts, and Optum Rx targeted independent pharmacies with burdensome audits after those pharmacies publicly supported PBM reform.

One allegation involves a medication costing just 99 cents that reportedly generated hundreds of hours of pharmacy staff work. The investigation is ongoing, and retaliation has not been established.

The big question: Are PBM audits protecting the system, or could they be used to intimidate pharmacies advocating for reform?

Read the congressional announcement

Special Guest: Dr. Jesse McCullough, PharmD

The 31 Day Challenge Finale & WORLD PHARMACIST CHALLENGE Announcement

Leadership starts with action!

Dr. Jesse McCullough, PharmD, CEO of Keystone Pharmacy Insights, returns to TWIRx for the final special feature of the 31 Day Challenge, reflecting on leadership, personal growth, accountability, and the importance of pharmacists stepping beyond their comfort zones.

We Are Main Street! NCPA 2026 Annual Conference Rewind | Part One29 Oct 202600:47:13

Hosted live in Kansas City, MO – the NCPA held their annual conference this year from October 3rd to the 6th! The Pharmacy Podcast Network brings you this exclusive coverage from within the YARAL Pharma booth, where Todd Eury, Host and CEO of the PPN, talks to vendors, pharmacy owners, and longtime friends in the industry. Listen in as we capture the best moments in conversation at this year's Community Pharmacy Super Bowl, the NCPA 2026 Annual Conference.

 

Thank you to YARAL Pharma for sponsoring this episode of the NCPA 2026 Rewind!

https://yaralpharma.com/

 

In this episode, we hear from:

Mark Garofoli PharmD - PainGuy.us

Betsy Powers Reynolds PharmD - MethodRx

Bretton Walberg PharmD - Owner of Care-Fill

Mitchell Cusey P3 - WVU

Tamara Cisneros PharmD - Liberty Software

Jay Phipps PharmD - The Pharmacy Gladiator

A Painful PGx Codeine Controversy | Pain Pod28 Oct 202600:22:03

Investigative reports, mount up! It’s time to question the longstanding pharmacogenic concerns for some prescription opioid pain medications! Come one, come all, to the Pain Pod!!! P.S. Want to contribute or hear about a pain pearl of your own? Message Pain Guy on www.painguy.us to directly reach Mark and have your voice heard! Pain Guy • www.painguy.us Codeine Guidance in Doubt After Calls for Retraction of Pivotal Lancet Study • http://doi.org/10.1136/bmj.s498 2006 Original Lancet Case Study • https://pubmed.ncbi.nlm.nih.gov/16920476/ 2020 The Implausibility of Neonatal Opioid Toxicity from Breastfeeding • https://pubmed.ncbi.nlm.nih.gov/32378749/ 2026 New Yorker Investigation • https://www.newyorker.com/magazine/2026/02/02/did-a-celebrated-researcher-obscure-a-fatal-poisoning 2026 Lancet “Expression of Concern” • https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00245-X/fulltext

 
The Peptide Possibilities Edition | Essential: The Pharmacy Compounding Podcast27 Oct 202600:37:56

As always, we have the most interesting (and important) news from the pharmacy compounding world, plus this episode we’ve got a deep dive into a future for peptides that protects patients while giving them access to the medications they want and need. Links from the episode Overview of the peptides issue (and recommendations): a4pc.org/peptides Overview of the ADT/DTE issue (and recommendations): a4pc.org/dte APC letter to California BoP about proposed out-of-state fee changes (1-page PDF): https://fllw.me/3Ued75S Washington Post story on potential (temporary) loosening of peptide regs: https://archive.is/fXroE Join APC: https://a4pc.org/join

inSPire 2026 Rewind; The Hub of Specialty Pharmacy | Part Five26 Oct 202601:00:59

The NASP's Annual Meeting and Expo has evolved into the first annual inSPire!

 

inSPire is the one week each year where innovation, networking, Specialty Pharmacy expertise, insights, research, and education come together to empower, educate, and connect our community.  

 

Join host Todd Eury, Founder and CEO of the Pharmacy Podcast Network as he covers this event LIVE in Nation Harbor, Maryland.

 

Thank you to our sponsors!

HendrenAI: https://hendren.ai/

First Databank: https://www.fdbhealth.com/

Clearway Health: https://www.clearwayhealth.com/

 

In today's episode, we hear from:

Richard Brook - Better Worldwide

Robert Giles - First Databank

Sam Medure - Inovalon

Shaun Jensen - JB Consulting

Srulik Dvorsky - TailorMed

Tim L Hommedieu - Plenful

Vivian Berni - Thermosafe

Independent Pharmacy: Power, Policy & Patient Care | TWIRx25 Oct 202601:17:41

October 23, 2026 Sponsored by Independent Pharmacy Cooperative and YARAL Pharma

This week on TWIRx: peptide compounding policy, a new hepatitis B treatment, specialty pharmacy growth, a rare-disease breakthrough, and pharmacy workforce pressure — followed by three conversations focused on the future of independent pharmacy.

TWIRx NEWS 1. FDA Moves Peptide Policy to White House Review

The FDA has submitted an Interim Access Policy for Compounding Using Certain Peptides for White House review. No final policy has been announced.

Why it matters: A temporary pathway could move some patients away from gray-market peptide sellers and toward licensed pharmacies, while raising ongoing questions about safety and evidence.

TWIRx angle: Is regulated compounding safer than leaving patients to buy peptides online?

2. FDA Approves GSK’s Hibsago for Chronic Hepatitis B

FDA approved Hibsago, bepirovirsen, for certain adults with chronic hepatitis B.

In Phase III studies, about 19% of eligible treated patients achieved functional cure after therapy stopped.

Why it matters: This could move hepatitis B treatment beyond long-term viral suppression toward sustained disease control for some patients.

3. Carelon Specialty Pharmacy Helps Drive Growth

Elevance Health reported $19.3 billion in quarterly Carelon revenue and about $900 million in operating gain, citing CarelonRx growth and improved specialty-pharmacy profitability.

Why it matters: Specialty pharmacy continues to become a major earnings and strategic growth engine inside vertically integrated healthcare organizations.

4. Positive Phase III Results for Bitopertin

Disc Medicine reported positive Phase III results for bitopertin in rare disorders where exposure to light can cause severe pain.

Patients experienced improved light tolerance and fewer phototoxic reactions.

Why it matters: This could meaningfully improve daily life for patients whose disease forces them to avoid sunlight.

5. Pharmacy Technicians Describe Growing Pressure

A widely discussed Reddit thread featured pharmacy technicians describing prescription backlogs, nonstop phones, frustrated patients, and inadequate staffing.

Important disclaimer: These are anonymous accounts and cannot be independently verified.

TWIRx angle: Are pharmacy teams being asked to do more without enough staffing and infrastructure?

FEATURED CONVERSATIONS Mark Kinney — IPC

IPC is expanding its Government Relations team as independent pharmacies face major federal and state issues involving PBM reform, reimbursement, rural access, and patient choice.

Discussion focus: Why IPC is investing more heavily in advocacy and what pharmacy owners should expect heading into 2027.

Shelley Bailey — IPC Rural Health and Independent Pharmacy

Independent pharmacies often serve as critical healthcare access points in rural communities.

Discussion focus:

  • Pharmacy closures and rural access
  • Chronic disease management
  • Pharmacist clinical services
  • Reimbursement and provider opportunities
  • Why rural pharmacies should be treated as healthcare infrastructure
Kelli Stovall, IPC + Brandon Haag, Tenovi Remote Monitoring Beyond the Pharmacy Counter

IPC and Tenovi are partnering to give independent pharmacies access to RPM and RTM technology, including blood pressure monitors, scales, smart pillboxes, and inhaler sensors.

The goal is to support:

  • Medication adherence
  • Hypertension and chronic disease management
  • Weight management
  • Respiratory care
  • Cash-pay and reimbursable clinical services

Big question: Can remote monitoring help independent pharmacies improve patient care while creating sustainable new revenue?

Closing

Independent pharmacy’s future increasingly depends on three things:

A stronger voice. A broader clinical role. Sustainable new economic models that keep care local.

TWIRx is sponsored by Independent Pharmacy Cooperative and YARAL Pharma. Independent Pharmacy: Power, Policy & Patient Care | TWIRx 

inSPire 2026 Rewind; The Hub of Specialty Pharmacy | Part Four22 Oct 202600:56:58

The NASP's Annual Meeting and Expo has evolved into the first annual inSPire!

 

inSPire is the one week each year where innovation, networking, Specialty Pharmacy expertise, insights, research, and education come together to empower, educate, and connect our community.  

 

Join host Todd Eury, Founder and CEO of the Pharmacy Podcast Network as he covers this event LIVE in Nation Harbor, Maryland.

 

Thank you to our sponsor, Clearway Health! For more information of what Clearway Health can do for your pharmacy, visit https://www.clearwayhealth.com/

 

In today's episode, we hear from:

 

Allison Arant - Clearway Health

Derek Dennis - Clearway Health

Ben Heiser - Lumicera

Chris Corsi - CassianRx

Chris Mayor & Candace Ewens - Kelly Services

Eric Huckins - Lumicera

Norma Castaneda - Fidelis Specialty Pharmacy

Endometriosis | SexPharmD21 Oct 202600:21:30

This episode discusses endometriosis- what it is, how it affects women, and the treatment options available. Plus, did you know that even Dolly Parton has shared her experience with endometriosis? Tune in as Dr Nadia sheds light on this often misunderstood condition and the importance of awareness and understanding.

 
Evaluating and Optimizing Health System Specialty Pharmacy Operating Models with Fairview Pharmacy Solutions | NASP Specialty Pharmacy Podcast20 Oct 202600:32:57

In this episode, Sheila Arquette, President & CEO of NASP, speaks with Mel Nelson, PharmD, CSP, Vice President, Specialty Consulting Services of Fairview Pharmacy Solutions. They discuss how the health system specialty pharmacy landscape has matured over the past decade, and why many organizations are now asking a new question: is our current operating model still the right one for where we want to go next? Mel walks through the key strategic, clinical, and financial factors health systems should evaluate when reassessing accelerator partnerships, the circumstances that might prompt a move toward insourcing capabilities, and how to protect patient care continuity through any transition. The conversation also covers how Fairview Pharmacy Solutions partners with health systems to design and execute successful transitions while building sustainable, long-term internal capability.

Access Against the Odds: How Pharmacists Navigate Shortages and Unmet Need | Love Your Pharmacist Awards presented by Clinigen19 Oct 202600:33:40

Sponsored by Clinigen | Love Your Pharmacist Awards

 

What happens when patients need critical medications, but traditional supply channels cannot deliver?

 

Medicine shortages, global supply disruptions, and unmet clinical needs are placing increasing pressure on healthcare systems worldwide. Behind every delayed shipment or unavailable treatment are pharmacists working tirelessly to find solutions, maintain continuity of care, and protect patients.

 

In this special episode of the Pharmacy Podcast Network, presented in partnership with Clinigen's Love Your Pharmacist Awards, we explore the essential role pharmacists play in overcoming barriers to medicine access across the United States and Europe.

 

Our featured guests bring unique perspectives on the challenges and innovations shaping global pharmaceutical access:

 

Alfred L'Altrelli – Chief Pharmacy Officer, Memorial Medical Center Las Cruces, and recipient of the 2026 Love Your Pharmacist Awards Lifetime Achievement Award. With nearly three decades of pharmacy leadership, Alfred has pioneered initiatives to improve medication safety, expand clinical pharmacy services, and strengthen healthcare access for underserved communities.

 

Louise Morshead – Pharmacist and Portfolio Director at Clinigen, based in the United Kingdom. Louise brings expertise in navigating global medicine supply challenges, working with suppliers and healthcare stakeholders to help address unmet patient needs.

 

In This Episode:

 

  • Why medicine shortages and supply disruptions continue to challenge healthcare systems worldwide.
  • How hospital pharmacists navigate medication access barriers while protecting patient safety.
  • What happens when essential medicines are unavailable through conventional supply channels.
  • The importance of international collaboration, innovative sourcing strategies, and continuity-of-care planning.
  • How pharmacists in the United States and Europe are adapting to increasingly complex medicine supply networks.
  • Why recognizing pharmacy leadership is essential to advancing patient-centered healthcare.

 

Pharmacists are more than medication experts. They are problem-solvers, patient advocates, and an essential connection between pharmaceutical supply and patient care.

 

Join us for an international conversation celebrating the pharmacists who go above and beyond to ensure patients aren't left behind when access becomes a challenge.

 

Presented by Clinigen and the Love Your Pharmacist Awards, in partnership with the Pharmacy Podcast Network.

 

Amplifying the Voice of Pharmacy.

 

#PharmacyPodcast #Clinigen #LoveYourPharmacist #MedicationShortages #MedicineAccess #HospitalPharmacy #PatientSafety #PharmacyLeadership #GlobalHealthcare #Pharmacists

inSPire 2026 Rewind; The Hub of Specialty Pharmacy | Part Three18 Oct 202600:56:40

The NASP's Annual Meeting and Expo has evolved into the first annual inSPire!

 

inSPire is the one week each year where innovation, networking, Specialty Pharmacy expertise, insights, research, and education come together to empower, educate, and connect our community.  

 

Join host Todd Eury, Founder and CEO of the Pharmacy Podcast Network as he covers this event LIVE in Nation Harbor, Maryland.

 

Thank you to our sponsors!

HendrenAI: https://hendren.ai/

First Databank: https://www.fdbhealth.com/

Clearway Health: https://www.clearwayhealth.com/

 

In today's episode, we hear from:

Jennifer Noonan - Accessia Health

Maggie Gahn - Andel

Matt Savard - Plenful

Maya Hajizada - Rx2Go

Mei Tang - Two Trees Consulting

Michael Depaz - Clarventa Lumicera

Michael Heimall - HealthWell Foundation

inSPire 2026 Rewind; The Hub of Specialty Pharmacy | Part Two15 Oct 202600:57:04

The NASP's Annual Meeting and Expo has evolved into the first annual inSPire!

 

inSPire is the one week each year where innovation, networking, Specialty Pharmacy expertise, insights, research, and education come together to empower, educate, and connect our community.  

 

Join host Todd Eury, Founder and CEO of the Pharmacy Podcast Network as he covers this event LIVE in Nation Harbor, Maryland.

 

Thank you to our sponsor, HendrenAI! For more information of what HendrenAI can do for your pharmacy, visit https://hendren.ai/

 

In today's episode, we hear from:

John Boos - HendrenAI

Andy Crawford - Keysource

Brandon & Jonathan Ogurhchak

Dustin Eubanks Plenful

Jennifer Iverson & Peter Bergen - AcariaHealth

The Medicare Checkup Nobody Told You About | Insights Beyond the Counter14 Oct 202600:23:58

Most people spend more time researching a new phone than reviewing their Medicare plan. But with benefits, costs, and pharmacy networks changing every year, staying in the same plan could mean paying more than you need to. In this episode, experts from Outcomes and Healthpilot break down Medicare in simple terms, explain why annual plan reviews matter, and discuss the key changes coming in 2027 that could affect healthcare and prescription costs. You'll walk away knowing what to discuss with your patients and why it matters.

 
Technicians Aren’t Asking for a Party with Mike Johnston | CPhT Connect12 Oct 202600:17:01

In this special "Off Script" episode of CPhT Connect, host Mike Johnston, CPhT-Adv, goes solo to speak directly to pharmacists, owners, managers, and anyone who builds the schedule. With World Pharmacy Technician Day coming up on Tuesday, October 20th, Mike shares what technicians told NPTA when asked one question: what would make you feel seen? Last year, 47% of technicians said no one recognized Pharmacy Technician Day at all, and Mike argues that recognition matters for retention, not just for being nice. Drawing on real responses from NPTA members, Mike explains why technicians aren't asking for a party. They're asking their employers to notice. He breaks their answers into two buckets: free recognition that costs only attention and recognition that costs something real, like pay that tracks the credentials, training, and responsibility they carry. Mike also speaks candidly to independent pharmacy owners working with thin margins, and closes with a simple three-step plan to use before October 20th. In this episode, we discuss: * It's a Noticing Problem, Not a Pizza Problem: Why the typical Tech Day pizza party is too generic to feel personal and too small to change anything, and why food showed up last on technicians' wish lists. * Bucket One: Recognition That Costs Nothing: What technicians said noticing looks like in their own words: don't cookie-cutter the appreciation, be fair, celebrate when they hit the goal, and see the work nobody sees. * Bucket Two: Recognition That Costs Something: Why technicians want pay that reflects their credentials, training, and responsibilities, and why keeping a tech is almost always cheaper than replacing one. * The Hidden Cost of Unused Skills: How training that sits on a shelf creates a morale problem, a retention problem, and a skill you paid for and never used, and why letting techs use what they learn may be the loudest recognition there is. * A Three-Step Plan Before October 20th: Write a specific sticky note for every technician, ask each one what would make them feel seen, and say it out loud to the whole team on Tech Day, then keep going on the 21st with one specific sentence to one tech every week. About Our Host: Mike Johnston, CPhT-Adv, is the founder and CEO of NPTA and founder of BPTS. He has owned his own company since 1999 and has spent more than 25 years helping thousands of pharmacy technicians grow their careers. This episode is part of CPhT Connect's partnership with the Pharmacy Podcast Network. Listen now at CPhTConnect.com to hear why one sentence is all it takes to show a technician you notice them. For free planning resources, visit RxTechDay.org, and to learn more about making recognition a year-round habit, explore the new Rx Team Builder program at cpht.org/employers

Cell & Gene Therapy Update with Joe DePinto, InspiroGene by McKesson | TWIRx09 Oct 202600:36:55

Cell and gene therapy has entered a new phase. The science is advancing rapidly, but the harder question is increasingly becoming: How do we actually get these therapies to the right patient, at the right treatment center, with the financing, logistics, clinical support, and follow-up required?

 

That is the problem McKesson is trying to address through InspiroGene, its dedicated cell-and-gene commercialization business. McKesson built InspiroGene to connect manufacturers, payers, providers, treatment centers and patients across the CGT journey. McKesson

 

1. McKesson: Building the infrastructure around the therapy

 

A major area of focus for Joe and McKesson is what happens after a therapy proves clinically viable.

 

In 2026, Joe DePinto and Biologics by McKesson outlined the need for patient hubs purpose-built specifically for cell and gene therapies. These are more complex than conventional specialty-drug hubs because CGT may involve eligibility screening, treatment-center coordination, benefit investigation, financial assistance, scheduling, logistics, long-term follow-up and caregiver support. McKesson Biologics

 

McKesson has also developed an interactive map covering qualified treatment centers across 109 U.S. metropolitan regions, addressing another fundamental problem: patients may need to travel significant distances to receive CGT. McKesson

 

Question for Joe: “Joe, the scientific breakthrough gets most of the headlines, but is the bigger challenge now building the infrastructure that allows a patient to actually receive the therapy?”

 

Follow-up: “Where do you currently see the biggest friction — reimbursement, treatment-center capacity, logistics, patient identification, or ongoing follow-up?”

2. FDA is actively trying to speed cell and gene therapy development

 

FDA has made a noticeable regulatory shift in 2026.

 

In June, FDA issued draft guidance allowing gene-therapy developers to rely more heavily on existing platform knowledge and prior scientific information, potentially reducing redundant testing for products using similar genome-editing technologies. FDA has also issued guidance providing more flexibility around chemistry, manufacturing and controls for CGT products. U.S. Food and Drug Administration

 

FDA says it has now approved close to 50 cell and gene therapies, signaling that CGT is moving well beyond a small experimental category. U.S. Food and Drug Administration

 

TWIRx takeaway: The regulatory conversation is shifting from “Can we safely approve these therapies?” toward “How do we safely accelerate an entire therapeutic platform?”

PBM Impact on Independent Pharmacy Owners | PBM Reform09 Oct 202600:46:30

A patient's copay unexpectedly jumped to nearly $500. Upon investigation, it was discovered his plan design had changed, penalizing him for using our pharmacy. He was now facing higher costs or needing to switch to a chain or mail-order pharmacy.

 
inSPire 2026 Rewind; The Hub of Specialty Pharmacy | Part One08 Oct 202600:56:06

The NASP's Annual Meeting and Expo has evolved into the first annual inSPire!

 

inSPire is the one week each year where innovation, networking, Specialty Pharmacy expertise, insights, research, and education come together to empower, educate, and connect our community.  

 

Join host Todd Eury, Founder and CEO of the Pharmacy Podcast Network as he covers this event LIVE in Nation Harbor, Maryland.

 

Thank you to our sponsor, First Databank! For more information of what FDB can do for your pharmacy, visit https://www.fdbhealth.com/

 

In today's episode, we hear from:

Dr Stephen Miller, MD - First Databank

Angela Johnston - First Databank

Bonnie Duggie - VytleOne

Christine Tang Wilson - Lumicera

Heather Bonome - URAC

Heidi Polek - Outcomes

Amit Gir - Phox Health

The Lots of News and State Taxes, Too Edition | Essential: The Pharmacy Compounding Podcast07 Oct 202600:33:19

Peptides. Animal-derived thyroid products. The perils of not documenting enough. A new recommendation for state regulation. And more. Besides the most interesting (and important) news from the pharmacy compounding world, this episode we’ve got a deep dive into the unique tax issues compounders face — which can be pretty darned daunting. Links from the episode APC issue brief on peptide compounding (two-page PDF): https://fllw.me/47mZu7b Citizen petition to FDA on compounding ADT (83-page (!) PDF): https://fllw.me/3VeA9tw FDA’s proposed GFI 256B — info and a chance to comment: https://www.regulations.gov/search?searchTerm=FDA-2018-D-4533 APC’s exclusive processing rates: https://apcpayments.com NABP’s model pharmacy act: https://nabp.pharmacy/members/board-resources/model-pharmacy-act-rules/ Sykes & Company Pharmacy Accounting Services: https://www.sykes-cpa.com/compounding-pharmacy-services

Healing in Community with Sacred Plant Medicine w/ Kathy Orah Sionit | The Holistic Pharmacy Podcast06 Oct 202600:55:11

My guest today bridges science and spirit, guiding clients toward embodied transformation, inner peace, and expanded consciousness. She affirms that everything you need is all within you, and you can learn to access it using various tools.I was so moved by her journey and multidimensional work, and I know you will love this episode as much as I do! Kathy Orah Sionit Shahkoohi is a licensed psychotherapist, master hypnotherapist, and intuitive healer with private practices in both Great Neck and Brooklyn, New York. She holds a Master’s degree in Social Work from the Wurzweiler School of Social Work (2008) and brings over 15 years of experience in trauma healing and somatic therapy. Kathy specializes in integrative trauma work, blending psychotherapy with somatic techniques, hypnotherapy, and spiritual healing modalities. As a certified master hypnotherapist, she focuses deeply on helping clients heal from early childhood wounds, anxiety, and subconscious patterning. She is also trained in Clarity Breathwork, a gentle yet profound somatic process that she offers to both individuals and groups for emotional release and nervous system regulation. Kathy regularly facilitates workshops on meditation, self-hypnosis, and inner healing across the country. In addition to her clinical work, Kathy holds sacred healing spaces through cacao ceremonies and psychedelic journeys, offering both preparation and integration support. Email: kathysionit@msn.com Website: innerlighttherapy.us IG: https://www.instagram.com/Kathysionit/ Visit https://marinabuksov.com for more holistic content. Music from https://www.purple-planet.com. Disclaimer: Statements herein have not been evaluated by the Food and Drug Administration. Products listed are not intended to diagnose, treat, cure, or prevent any diseases.

Patients Rising Rx with Terry Wilcox | PBM Reform with APCI05 Oct 202600:34:50

This is part one of a two part conversation with Terry Wilcox, Co-Founder and CEO of Patients Rising. Find out what Patients Rising is doing for advocacy and change to better our patients by visiting https://www.patientsrising.org/about-patients-rising

Independent Pharmacy: AI, Consolidation & Fighting for Every Dollar | TWIRx02 Oct 202600:53:48

This week on TWIRx, we head into NCPA 2026 with independent community pharmacy front and center — from artificial intelligence and consolidation to supply-chain economics and policy reform.

 

We start with the TWIRx Rumor Mill — Behind the Counter Intelligence, looking at three developing stories worth watching.

 

TWIRx RUMOR MILL — TOP 3

 

1. Another massive pharmacy transaction may be coming.

 

The owner of Walgreens Boots Alliance is reportedly nearing a deal to sell UK pharmacy giant Boots to the Weston family in a transaction valued at roughly $9 billion, including debt. The Weston interests already control Loblaw Companies and Shoppers Drug Mart in Canada. No final transaction has been announced, so this remains one to watch.

 

TWIRx Take: Pharmacy consolidation isn't slowing down. As major organizations continue reorganizing, buying, selling, and vertically integrating assets, what does that mean for independent pharmacy — and where does scale become too much scale?

 

 

2. Specialty pharmacy keeps getting bigger — and Cigna sees an enormous opportunity.

 

At its 2026 Investor Day, Cigna identified a specialty pharmacy and care-services market approaching $500 billion, with Accredo and its specialty operations positioned as major growth drivers.

 

TWIRx Take: Follow the money. Specialty drugs, rare disease, biologics, infusion and complex medication management continue to reshape pharmacy economics. The question for community pharmacy is: How much of this expanding market can independents capture?

 

3. AI is moving from pharmacy experiment to pharmacy infrastructure.

 

Just as NCPA prepares to make AI implementation one of the major topics at its 2026 Annual Convention, health-profession regulators are increasingly discussing governance and accountability surrounding AI. NCPA's programming includes real-world AI implementation and operational applications for community pharmacies.

 

TWIRx Take: The conversation is changing from "Should pharmacy use AI?" to "How do we use it responsibly, profitably and safely?"

 

And that takes us directly into our first featured conversation.

 

SEGMENT 1 John Boos, PharmD, MBA — HendrenAI AI Meets Independent Community Pharmacy

 

Sponsored by HendrenAI and Independent Pharmacy Cooperative

 

NCPA 2026 officially opens October 3 in Kansas City, with independent pharmacy owners and innovators gathering to focus on practical ways to increase efficiency, expand services and strengthen pharmacy profitability. AI implementation is specifically among this year's featured topics.

 

In Part One of our conversation with John Boos, PharmD, MBA of HendrenAI, we set the stage for NCPA 2026 and examine what artificial intelligence can realistically do for independent pharmacy.

 

This isn't AI replacing the pharmacist.

 

It's AI giving pharmacists and their teams additional capacity.

 

As margins tighten and workload continues to increase, the pharmacies that intelligently automate routine work may be able to redirect valuable human time toward the things pharmacists do best: patients, clinical care, relationships and growing the business.

 

SEGMENT 2 Yvonne Dominguez — Independent Pharmacy Cooperative IPC Acquires IntegralRx

 

Independent Pharmacy Cooperative recently announced its acquisition of IntegralRx, bringing together two organizations serving independent community pharmacies.

 

IntegralRx has supported thousands of pharmacies through purchasing opportunities, service and pharmacy relationships. IPC says the acquisition will expand access to products, services and resources designed to help pharmacy owners remain competitive and profitable.

 

We talk with Yvonne Dominguez about:

 

  • Why IPC made the acquisition
  • What IntegralRx brings to the cooperative
  • What changes — and what stays the same — for IntegralRx pharmacies
  • How scale can strengthen independent pharmacy purchasing power
  • Why independent pharmacies increasingly need collaboration without surrendering their independence

 

TWIRx Question: Can cooperatives create enough collective scale to give independent pharmacies some of the economic leverage enjoyed by vertically integrated competitors?

 

SEGMENT 3 David A. Hargraves — CEO, Pharma Logistics Jessica Daley — Industry Intelligence Pharmacy Supply Chain: Fighting for Every Dollar

 

Finally, we turn to an issue that doesn't always generate headlines but directly affects pharmacy profitability:

 

What happens to medication inventory after a pharmacy can no longer use it?

 

Pharmacies continue to face significant economic pressure, and many of the largest forces affecting reimbursement remain outside the direct control of the pharmacy owner.

 

But there are areas pharmacies — and policymakers — can change.

 

One is pharmaceutical return policy.

 

The Problem

 

Pharmacy economics are being squeezed from multiple directions.

 

Reimbursement pressure. Inventory expense. Expired medication. Operational costs. Supply-chain complexity.

 

When margins are razor thin, seemingly small inefficiencies become substantial.

 

The Opportunity

 

Medication return policies represent an area where pharmacies may have an opportunity to recover value that otherwise disappears from the business.

 

Virginia's regulations, for example, specifically address circumstances under which drugs can be returned within the supply chain while maintaining appropriate storage conditions, documentation and product integrity.

 

The Bigger Conversation

 

With David A. Hargraves, CEO of Pharma Logistics, and Jessica Daley of Industry Intelligence, we examine how smarter pharmaceutical returns and responsible policy reform could improve pharmacy economics.

 

Closing Thought

 

As we head into NCPA 2026, the independent pharmacy conversation isn't simply about surviving another difficult year.

 

It's about finding leverage.

 

Leverage through AI.

 

Leverage through cooperative scale.

 

Leverage through better supply-chain economics.

 

And leverage through policy change.

 

Independent pharmacy may not control every economic force affecting the profession — but this week's TWIRx demonstrates that there are still areas where pharmacy owners, innovators and advocates can take action.

 

We'll see you in Kansas City for NCPA 2026.

Female Pelvic Health with Dr Sarah Apple | SexPharmD01 Oct 202600:19:50

In this podcast episode, I interview Dr. Sarah Apple, a board-certified occupational therapist and the owner of Happy Pelvis Pelvic Floor Therapy in Cookeville, TN. Dr Apple talks about how she has dedicated her practice to helping women better understand and care for their pelvic health. In addition, we discuss how pelvic health relates to sex therapy. Dr Sarah Apple's Bio: Dr. Sarah Apple is a board-certified occupational therapist and the owner of Happy Pelvis Pelvic Floor Therapy, a local practice in Cookeville, TN dedicated to helping women better understand and care for their pelvic health. She specializes in pelvic floor therapy through pregnancy, postpartum, and beyond, with a passion for helping women recognize that common symptoms aren’t always something they simply have to live with. Through Happy Pelvis, Sarah strives to educate, empower, and help women feel confident in their bodies. Practice Website: https://www.happypelvistherapy.com/ Facebook Link: https://www.facebook.com/profile.php?id=61565217837049 LinkedIN: https://www.linkedin.com/in/sarah-apple-otd-otr-l-58817a236/

Infusion, Distributor Cut-offs, Nexus Issues, Personal Guarantees, Financing | The Bottom Line Rewind30 Sep 202600:27:00

Welcome everyone to the Bottom Line Rewind, your monthly recap of the Bottom Line Pharmacy Podcast. This month, we feature interviews on topics about operating an Infusion pharmacy in 2026, distributor cutoffs, peptides, and personal guarantee insurance. Click below to check out the full episodes: Episode 1: Infusion Pharmacy Ownership in 2026: https://youtu.be/rdMKsMjN8Zs?si=jqZq-MXU7IVk3KmB Episode 2: Distributor Injunctive Relief: https://youtu.be/hAAo6AY-Ai0?si=2nbb6GVyaN9qr44A Episode 3: Peptides, Nexus Issues, and Tradeshow Takeaways: https://youtu.be/8_clXDyhVbM?si=2s-6je4YAG26889m Episode 4: Personal Guarantee Insurance 101: https://youtu.be/4v3cRtMvfIM?si=k0h36O_CIc7-IaCC Episode 5: Financing a Pharmacy Acquisition: https://youtu.be/CYxfBISoBco?si=kzEzUdmUh6YHXRvz

Talking Medication Safety in Specialty Pharmacy with ISMP | NASP Specialty Pharmacy Podcast29 Sep 202600:28:46

In this episode, Sheila Arquette, President & CEO of NASP, speaks with Rita Jew, PharmD, MBA, President of the Institute for Safe Medication Practices (ISMP), about what it takes to keep specialty medication use safe. They discuss the distinct risks of specialty medications and detail ISMP's mission to prevent medication errors, providing drug-specific risk assessments, resources, and interactive tools that help pharmacies uncover gaps between policy and practice.

The Future of Long-Term Care Pharmacy: AI, Automation & New Revenue Models | SuiteCast28 Sep 202600:37:26

Thomas E. Hanzel joins host Todd Eury to discuss how AI, automation, data access, and emerging at-home care models can help long-term care pharmacies improve efficiency, expand patient care, and diversify revenue.

Host: Todd Eury Guest: Thomas E. Hanzel, PharmD, MBA

A Conversation with Vox: An AI Perspective on Pharmacy’s Future | TWIRx26 Sep 202600:19:40

In this special episode of This Week in Pharmacy, Todd Eury welcomes Vox, the PPN and RxPR Intelligence Officer, for a timely conversation about the forces reshaping pharmacy.

Together, they examine the reimbursement pressures threatening independent pharmacies, the progress—and unfinished work—of PBM reform, and how artificial intelligence can augment pharmacists, strengthen operations, and create more time for meaningful patient care.

The discussion also looks ahead to NCPA 2026 in Kansas City, emerging innovations from Hendren AI and FDB, YARAL Pharma’s support of community pharmacy, and the upcoming Veterans Pharmacy Care Summit.

The message is clear: pharmacists and pharmacy technicians must engage lawmakers, host pharmacy tours in 2027, and share the patient stories that demonstrate pharmacy’s value.

This is not our platform. This is your platform.

The Future of Pharmacy Where Next for the Profession | Love Your Pharmacist Awards presented by Clinigen25 Sep 202600:32:34

In Episode 2 of our special podcast series presented in partnership with Clinigen, we celebrate World Pharmacists Day by examining how hospital pharmacy is changing—and where the profession may be headed next.

 

Host Todd Eury welcomes Carel Bouwer, a pharmacist and Managing Director for Clinigen’s Africa region, and Nicolene Schoeman, Dispensary Manager at Zuid-Afrikaans Hospital in South Africa.

 

Together, they explore the hospital pharmacist’s position at the intersection of science and humanity. Although hospital pharmacists are recognized for their knowledge of medicines, their ability to listen, understand individual patient experiences, and help people navigate complex treatment journeys is equally important.

 

The conversation addresses the pressures reshaping hospital pharmacy, including increasing prescription volumes, workforce shortages, financial constraints, emerging therapies, and changing patient expectations. Carel and Nicolene discuss how the profession can meet these demands without losing the pharmacist-patient relationship that has traditionally defined pharmacy practice.

 

Topics include:

 

  • What people misunderstand about the work pharmacists perform
  • How pharmacy education must evolve for the next generation
  • Pharmacogenomics, personalized medicine, AI, and digital health
  • Preparing pharmacists for business and operational leadership
  • Integrating pharmacists into multidisciplinary care teams
  • Hospital pharmacists’ often-unseen contributions to patient care
  • Pharmacy-led care and its potential to reduce pressure on physicians and hospitals
  • Antibiotic stewardship and expanded clinical responsibilities
  • The continued growth of specialist and prescribing roles

 

Looking ahead, the guests consider a future in which technology manages more routine tasks while pharmacists assume greater responsibility for personalized medicine, clinical decision-making, prescribing, and direct patient care.

 

The future of pharmacy will be more technologically advanced—but its success will still depend on human judgment, empathy, communication, and trust.

 

 

 

Host: Todd S. Eury Guests: Carel Bouwer and Nicolene Schoeman Presented in partnership with: Clinigen

Iowa’s PBM Reform Breakthrough: Inside Senate File 383 | PBM Reform with APCI24 Sep 202600:30:35

Guest: Iowa State Representative Brett Barker, PharmD — District 51 Guest Host: Todd S. Eury, Pharmacy Podcast Network Regular Host: Greg Reybold — on special assignment Sponsored by: American Pharmacy Cooperative, Inc. (APCI)

 

Iowa has delivered one of the most significant state-level victories in the continuing fight for pharmacy benefit manager reform.

 

On this episode of the PBM Reform Podcast, guest host Todd S. Eury sits down with Iowa State Representative Brett Barker, PharmD, a practicing pharmacist and representative of Iowa House District 51, for an inside look at the passage of Senate File 383 and what the new law could mean for independent pharmacies, employers, patients and the future of PBM regulation across the country.

 

Representative Barker brings a rare perspective to the discussion. In addition to serving in the Iowa Legislature, he is a pharmacist and pharmacy executive who understands firsthand the financial pressures facing community pharmacies. Barker served as one of the House floor managers for SF 383 as the legislation moved through the Iowa General Assembly.

 

The legislation cleared the Iowa House by a 75–15 vote after previously passing the Senate 36–14. Governor Kim Reynolds signed SF 383 into law on June 11, 2025, and its primary provisions became effective July 1, 2025.

 

SF 383 establishes substantial new requirements governing pharmacy benefit managers and their relationships with pharmacies, health plans and other payors. Among its provisions, the law addresses PBM reimbursement practices, pharmacy contracting, pass-through pricing, pharmacy appeals and disputes, network participation and protections intended to prevent discriminatory treatment of pharmacies.

 

One of the central themes of the legislation is greater transparency and accountability surrounding the flow of prescription-drug dollars. The law defines and establishes requirements involving pass-through pricing, in which payments made by a third-party payor to a PBM for prescription drugs correspond to payments made to the dispensing pharmacy, including applicable professional dispensing fees.

 

During the conversation, Todd and Representative Barker explore:

 

  • Why PBM reform became such an urgent issue for Iowa pharmacists and patients.
  • What community pharmacies were experiencing financially before SF 383.
  • How pharmacists, pharmacy owners and advocacy organizations helped educate Iowa lawmakers.
  • The political battle surrounding the legislation and what ultimately helped generate bipartisan support.
  • Why PBM reimbursement methodology is central to pharmacy sustainability.
  • The importance of giving pharmacies meaningful mechanisms to challenge reimbursement and contractual disputes.
  • The role Representative Barker's pharmacy background played in explaining PBM economics to fellow legislators.
  • The opposition lawmakers encountered while attempting to move PBM reform forward.
  • What other states can learn from Iowa's strategy.
  • Why pharmacists need greater representation inside state legislatures.
  • Whether Iowa's legislation could become a model for broader PBM reform nationwide.

 

Governor Reynolds described the legislation as an effort to bring greater accountability to PBMs and noted when signing the bill that Iowa was joining a growing number of states pursuing similar reforms.

 

For independent community pharmacists, the Iowa experience demonstrates something increasingly important: PBM reform is no longer simply a pharmacy reimbursement debate. It is becoming a healthcare access, competition and patient-care issue being fought state by state.

 

Representative Barker's story also highlights another major theme of the PBM Reform Podcast — the importance of pharmacists becoming directly engaged in public policy.

 

When pharmacists bring their clinical knowledge, business experience and patient relationships into state government, they can help lawmakers understand how policies written hundreds of miles away ultimately affect whether a pharmacy can keep its doors open.

 

Iowa's passage of SF 383 represents a major milestone in that movement.

 

About Our Guest

 

Brett Barker, PharmD, represents Iowa House District 51. He earned his Doctor of Pharmacy degree from the University of Iowa and has worked extensively in community pharmacy. His professional background gives him firsthand insight into pharmacy operations, prescription-drug reimbursement and the challenges facing independent pharmacies.

 

About the PBM Reform Podcast

 

The PBM Reform Podcast examines pharmacy benefit manager practices, prescription-drug economics, legislation and public policy affecting pharmacists, employers and patients across the United States.

 

The program features pharmacists, policymakers, healthcare executives, legislators and advocacy leaders working to create greater transparency, accountability and competition within the prescription-drug marketplace.

 

Sponsored by American Pharmacy Cooperative, Inc. (APCI).

 

Guest Host: Todd S. Eury Regular Host: Greg Reybold — on special assignment Production: Pharmacy Podcast Network

 

PBM Reform Podcast — following the legislation, the policymakers and the pharmacists fighting to change the prescription-drug marketplace.

LIVE at RBC 2026 Episode Three | Cardinal Health™ CounterTalk™ Podcast23 Sep 202601:01:28

Tune into a multi-episode recap of the Retail Business Conference (RBC) 2026, hosted by Corey Huckabey, Director of Customer Experience, and Semaki Corfias, Sr. Manager, Customer Care. Throughout this series, Corey and Semaki sit down with Cardinal Health leaders, industry experts, pharmacy owners, and solution specialists to discuss the trends, innovations, and opportunities transforming independent pharmacy. Hear exclusive conversations and actionable insights directly from the RBC 2026 show floor.

Episode Breakdown

• Inventory Optimization: Unlocking the Future of Inventory Management – Hear how pharmacy owner Jason Kizer implemented Inventory Optimization and his experience on the benefits of the program compared to Cardinal Health Inventory Optimization (CIM). 

• ContinuCare Pathway: Bridging the Gap in Diabetes Supplies – Learn how the ContinuCare Pathway Program can help pharmacies streamline access to Cardinal Health’s direct-to-patient DME provider for diabetes devices and supplies. 

 
LIVE at RBC 2026 Episode Two | Cardinal Health™ CounterTalk™ Podcast23 Sep 202600:34:35

Tune into a multi-episode recap of the Retail Business Conference (RBC) 2026, hosted by Corey Huckabey, Director of Customer Experience, and Semaki Corfias, Sr. Manager, Customer Care. Throughout this series, Corey and Semaki sit down with Cardinal Health leaders, industry experts, pharmacy owners, and solution specialists to discuss the trends, innovations, and opportunities transforming independent pharmacy. Hear exclusive conversations and actionable insights directly from the RBC 2026 show floor.

Episode Breakdown

• Vantus™ HQ Updates and Customer Communications – Discover how Vantus HQ turns customer feedback into meaningful enhancements to the platform and enhances customer experience.

• Experience Digital Growth and Engagement with Cardinal Health E.D.G.E. –

Independent pharmacies are at a crossroads, where tradition meets transformation. Learn how Cardinal Health and Lumistry break down strategies to help independent pharmacies stay competitive in today’s challenging digital landscape.

LIVE at RBC 2026 Episode One | Cardinal Health™ CounterTalk™ Podcast23 Sep 202600:49:48

Tune in to a multi-episode recap of the Retail Business Conference (RBC) 2026, hosted by Corey Huckabey, Director of Customer Experience, and Semaki Corfias, Sr. Manager, Customer Care. Throughout this series, Corey and Semaki sit down with Cardinal Health leaders, industry experts, pharmacy owners, and solution specialists to discuss the trends, innovations, and opportunities transforming independent pharmacy. Hear exclusive conversations and actionable insights directly from the RBC 2026 show floor.

Episode Breakdown

• From Card to Counter Making Medicare Advantage OTC Benefits Work In Your Pharmacy – Discover how independent pharmacies can unlock the value of Medicare Advantage OTC benefits. Learn how pharmacies can strengthen patient relationships, drive front-end sales and growth within their pharmacy.

• Strengthening Support for an Aging Population – Learn how AARP's HomeFit Guide helps individuals create safer, more accessible homes through practical home safety and accessibility strategies that support independence and aging in place.

 
Manufacturer Direct D2C and the Future of Independent Pharmacy | TWIRx Special Series22 Sep 202600:40:34

In this IPC-sponsored episode, Todd Eury explores how manufacturer-direct programs, direct-to-consumer channels, cash-pay models, specialty carve-outs, and new reimbursement structures are reshaping medication access and independent pharmacy.

 

Joining the conversation are Shelley Bailey of Independent Pharmacy Cooperative and Sammy Salem, Principal Owner and COO of Vios Health and an Executive Board Member of AAPARx.

 

Manufacturer-direct care is often associated with websites, telehealth, and mail-order fulfillment—but it does not have to exclude community pharmacy. IPC is developing infrastructure that allows patients to receive manufacturer-supported pricing while participating independent pharmacies remain the dispensing location.

 

The discussion examines IPC’s manufacturer-sponsored GLP-1 opportunities and a broader network covering more than 140 branded medications. Shelley and Sammy explain how these programs can improve patient affordability, create more sustainable pharmacy economics, and help independent pharmacies reconnect with patients lost to online and manufacturer-controlled channels.

 

Topics include:

 

  • Whether the traditional pharmacy benefit is beginning to fragment
  • How manufacturer-direct programs can include independent pharmacy
  • The economics behind manufacturer-supported reimbursement
  • Finding patients facing denied authorizations, high deductibles, lost coverage, or limited brand access
  • Why excellent service must now be paired with digital access and new payment models
  • Employer drug carve-outs and the importance of evaluating total benefit economics
  • Point-of-sale affordability and acquisition-cost protections
  • What manufacturers need to provide for pharmacy participation
  • How successful pharmacies can prepare for the next access model

 

The central message is clear: the industry may not need to create new dollars—it needs to change where existing dollars land.

 

In partnership with GoodRx, this manufacturer-direct program combines GoodRx’s trusted consumer platform and broad patient reach with IPC’s nationwide network of independent pharmacies. Together, we create a more direct and accessible path from patient engagement to prescription fulfillment—while keeping community pharmacies at the center of care.

 

IPC GPO members interested in participating should contact their IPC Regional Director. Other IPC members, affiliates, and interested pharmacies can reach IPC Digital Health at digital-health@ipcrx.com.

 

Host: Todd S. Eury, Pharmacy Podcast Network Guests: Shelley Bailey, IPC; Sammy Salem, AAPARx and Vios Health Sponsored by: Independent Pharmacy Cooperative

The Prescriber Goes Dark Reconnecting the Provide | ONE Journey Ending Fragmentation in Specialty Care with CassianRx21 Sep 202600:37:37

A specialty prescription can pass through a payer, PBM, hub, specialty pharmacy, provider’s office, and manufacturer support program before the patient receives the first dose. At every handoff, critical time, information, and patient confidence can be lost.

 

In Episode 1 of this three-part series, Todd Eury and leaders from AcariaHealth and CassianRx examine where fragmentation often begins: the moment a specialty prescription is written and the prescriber loses visibility into what happens next.

 

The conversation explores AcariaHealth’s use of the CassianRx ONE Journey physician portal to reconnect prescribers and their staff with the specialty pharmacy process. The platform provides NPI-scoped access to prescription status, shipment history, patient information, secure two-way communications, and document exchange.

 

The episode also examines why provider adoption is an experience challenge—not simply a technology challenge. Even the most advanced portal delivers limited value if it creates another login, adds complexity, or fails to provide immediate and meaningful information.

Topics include:

  • The true cost of status calls, faxes, and disconnected workflows
  • Improving transparency from referral through dispensing
  • Designing technology that prescribers and office staff will use
  • Secure communication between practices and specialty pharmacies
  • Scaling the provider experience across a national specialty operation
  • The appropriate role of AI in specialty pharmacy workflows
  • How provider connectivity can accelerate patients’ access to therapy

The episode closes with the series’ recurring question: What is the one handoff you would eliminate?

Episode 1 establishes the provider layer of the specialty journey before Episode 2 shifts attention to the person still navigating access, affordability, onboarding, and treatment—the patient.

 

Hosted by: Todd S. Eury, Pharmacy Podcast Network Featuring: AcariaHealth and CassianRx

  • Chris Corsi - CEO CassianRx
  • Paige Davis - Vice President Product and Client Success
  • Peter Bergen - Acaria Health Vice President - Pharmacy Operations
  • Jennifer Iverson - AcariaHealth Vice President, Product, Clinical and Data Strategy

Series sponsor: CassianRx and the ONE Journey platform

 

One patient. One journey. Every stakeholder.

Pharmacists at the Center: Public Health, AI & the New Pharmacy Model | TWIRx18 Sep 202601:18:34

This week on TWIRx, we’re looking at the expanding role of pharmacists in public health, value-based care, artificial intelligence, medication intelligence, and the technology infrastructure supporting independent community pharmacy.

 

We begin with a special conversation featuring Alex J. Adams, PharmD, MPH, Assistant Secretary for the Administration for Children and Families (ACF), and Pennsylvania pharmacy leader Robert “Rob” Maher, PharmD, President and Chief Operating Officer of the Pennsylvania Pharmacists Care Network (PPCN).

 

Dr. Adams brings a pharmacist’s perspective to federal health and human services leadership, while Maher leads a statewide clinically integrated pharmacy network focused on measurable patient outcomes. Together, we discuss how pharmacists are becoming increasingly involved in public health initiatives and how organizations such as PPCN are helping demonstrate the value of pharmacist-provided care through value-based models in Pennsylvania.

 

Next, we continue our countdown to NASP inSPire 2026 with one of PPN’s Podcast Press Sponsors, Hendren AI.

 

John Boos, PharmD, MBA, Founder and CEO of Hendren AI, joins us to examine the growing role of artificial intelligence in specialty pharmacy and rare disease management. We discuss how AI-enabled tools can support pharmacists by processing complex information, improving workflow efficiency, automating administrative processes, and helping pharmacy teams devote more time to clinical care and patient engagement.

 

Our 3rd segement on today’s TWIRx, we catch up with Vince Costanzo of RxBLU for an important discussion about the rapidly changing pharmacy technology landscape.

 

Pharmacy software today is about far more than features and functionality. For an independent pharmacy, its technology platform can sit at the center of dispensing, claims, inventory, patient communication, workflow, and business continuity.

 

We discuss why pharmacies should evaluate not only the technology they purchase, but also the stability, accessibility, support structure, and long-term strategy of the company behind it. As consolidation continues throughout healthcare technology, independent pharmacy owners need to understand what a potential acquisition, ownership change, or shift in corporate priorities could mean for the software platforms their operations depend upon.

 

Our featured Podcast Press Sponsor is First Databank — FDB.

 

David Delaney, MD, President of FDB, joins TWIRx to discuss the company's newly announced FDB Script Agent™, an AI-powered prescribing agent designed to move ambient listening beyond clinical documentation.

 

FDB Script Agent converts patient-clinician dialogue into structured prescriptions ready for clinician review, using FDB medication intelligence to provide clinical grounding and codification rather than relying on simple natural-language processing alone. We explore what this next generation of ambient AI could mean for prescribing workflows, medication safety, clinicians, and ultimately the pharmacies receiving those prescriptions.

 

It’s another packed edition of This Week in Pharmacy — connecting pharmacy leadership, public health, specialty pharmacy, artificial intelligence and the technology shaping the future of the profession.

 

This is TWIRx — This Week in Pharmacy, from the Pharmacy Podcast Network.

The Evolving Role of Hospital Pharmacy | Love Your Pharmacist Awards presented by Clinigen17 Sep 202600:48:32

Hospital pharmacy is evolving rapidly — and pharmacists are playing a more influential role than ever in shaping safe, personalised and effective patient care.

In this first episode of a special three-part series presented in partnership with Clinigen’s Love Your Pharmacist Awards, we explore how hospital pharmacy has transformed from a traditionally dispensing-focused profession into a highly clinical, technology-enabled and collaborative discipline.

Host Todd Eury welcomes Dr. Varun Sethi, SVP, Asia-Pacific and Japan Region at Clinigen, and Alison Tennant, former Chief Pharmacist and recipient of the 2025 Love Your Pharmacist Lifetime Achievement Award.

Together, they discuss how pharmacists are helping solve complex treatment challenges, manage medicine shortages, support multidisciplinary clinical decisions and improve access to specialised therapies. The conversation also examines the growing influence of artificial intelligence, electronic prescribing, automation, pharmacogenomics and personalised medicine — and why human judgement, empathy and patient advocacy remain irreplaceable.

The episode also looks ahead to emerging innovations including advanced formulations, precision therapies and 3D-printed medicines.

At the heart of the discussion is a simple message: hospital pharmacists are often working behind the scenes, but their impact can be felt throughout the entire patient journey.

The Love Your Pharmacist Awards celebrate those extraordinary contributions.

© My Podcast Data · Projet indépendant · Données issues d'Apple & Spotify